IP Library Granted Patent US 7,611,500
Granted Patent B1
US 7,611,500 · App. 08/951,832 · Granted Nov 3, 2009

Wound therapy device and related methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,611,500
App. No.
08/951,832
Granted
Nov 3, 2009
Kind
B1
Abstract

A wound closure apparatus is disclosed which includes a housing that contains a vacuum pump and a chamber for holding a disposable wound fluid collection canister. The canister resides within the chamber and connects at an outlet with the vacuum pump and at an inlet with a pad. The pad is placed over a wound and adhesively secured thereto. When the vacuum pump activates, it evacuates air from the canister resulting in wound fluids flowing from the wound into the canister. After the canister is filled, it is removed from the chamber and replaced with another canister to continue the removal of wound fluids.

Claims (45)

1. A therapeutic combination of promoting tissue healing, comprising:

a porous pad which is permeable to fluids;

a tube having a first end in fluid communication with said porous pad;

a canister for collecting fluids drawn through said tube, said canister being fluidly connected with a second end of said tube which is opposite the first end of said tube, wherein said canister is removably received in a recess in a housing;

a suction pump for applying negative pressure to said tube, said suction pump being fluidly connected to said canister;

at least one bacterial filter between said canister and said suction pump;

an elastomeric film dressing having a pressure-sensitive adhesive in peripheral areas for securing said porous pad to tissue within a sealed space;

a sensor for detecting when said canister is substantially full with fluid, said sensor being associated with said suction pump to discontinue application of the negative pressure when a substantially full condition of said canister is detected; and

a switch providing a signal indicating that the canister properly resides within the recess when the switch is pressed.

2. A therapeutic combination as claimed in claim 1 wherein the housing houses said suction pump.

3. A therapeutic combination as claimed in claim 1 wherein said tube is fitted as an interference fit into an interior portion of said porous pad.

4. A therapeutic combination as claimed in claim 1 wherein said porous pad comprises a polymer foam having interconnecting cells.

5. A therapeutic combination as claimed in claim 4 wherein said polymer foam is a polyether reticulated foam having at least 95% interconnecting cells.

6. A therapeutic combination as claimed in claim 1 wherein said porous pad comprises a reticulated foam having at least 90% interconnecting cells.

7. A therapeutic combination as claimed in claim 1 wherein said porous pad comprises a reticulated foam having at least 95% interconnecting cells.

8. A therapeutic combination as claimed in claim 1 further comprising a tilt sensor for determining tilting of said therapeutic combination beyond a predetermined angle, said tilt sensor being associated with said suction pump to discontinue application of the negative pressure when tilting of said therapeutic combination beyond said predetermined angle is detected.

9. The therapeutic combination of claim 1 , wherein the peripheral areas with the pressure-sensitive adhesive extend beyond a periphery of the porous pad for adhering to intact skin around a wound.

10. A therapeutic combination of promoting tissue healing, comprising:

a porous pad which is permeable to fluids;

a tube having a first end in fluid communication with said porous pad;

a canister for collecting fluids drawn through said tube, said canister being fluidly connected with a second end of said tube which is opposite the first end of said tube, wherein said canister is removably received in a recess in a housing;

a suction pump for applying negative pressure to said tube, said suction pump being fluidly connected to said canister;

at least one bacterial filter between said canister and said suction pump;

an elastomeric film dressing having a pressure-sensitive adhesive in peripheral areas for securing said porous pad to tissue within a sealed space;

a tilt sensor for determining tilting of said therapeutic combination beyond a predetermined angle, said tilt sensor being associated with said suction pump to discontinue application of the negative pressure when tilting of said therapeutic combination beyond said predetermined angle is detected; and

a switch providing a signal indicating that the canister properly resides within the recess when the switch is pressed.

11. A therapeutic combination as claimed in claim 10 wherein said tube is fitted as an interference fit into an interior portion of said porous pad.

12. A therapeutic combination as claimed in claim 10 wherein said porous pad comprises a polymer foam having interconnecting cells.

13. A therapeutic combination as claimed in claim 10 wherein said porous pad comprises a reticulated foam having at least 90% interconnected cells.

14. A therapeutic combination of promoting tissue healing, comprising:

a porous pad which is permeable to fluids;

a tube having a first end in fluid communication with said porous pad;

a canister for collecting fluids drawn through said tube, said canister being fluidly connected with a second end of said tube which is opposite the first end of said tube, wherein said canister is removably received in a recess in a housing;

a suction pump for applying negative pressure to said tube, said suction pump being fluidly connected to said canister;

at least one bacterial filter between said canister and said suction pump;

an elastomeric film dressing having a pressure-sensitive adhesive in peripheral areas for securing said porous pad to tissue within a sealed space;

a sensor for detecting when said canister is substantially full with fluid, said sensor being associated with said suction pump to discontinue application of the negative pressure when a substantially full condition of said canister is detected;

a tilt sensor for determining tilting of said therapeutic combination beyond a predetermined angle, said tilt sensor being associated with said suction pump to discontinue application of the negative pressure when tilting of said therapeutic combination beyond said predetermined angle is detected; and

a switch providing a signal indicating that the canister properly resides within the recess when the switch is pressed;

wherein said porous pad comprises a reticulated foam having at least 90% interconnecting cells; and

wherein the peripheral areas with the pressure-sensitive adhesive extend beyond a periphery of the porous pad for adhering to intact skin around a wound.

15. A therapeutic combination as claimed in claim 1 further comprising:

a latch securing the canister in the recess in the housing.

16. A therapeutic combination as claimed in claim 1 , wherein the canister includes a transparent window.

17. A therapeutic combination as claimed in claim 8 , wherein the predetermined angle is about 45 degrees.

Assignments (9)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Feb 6, 2017
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: KCI LICENSING, INC., AS GRANTOR; TECHNIMOTION, LLC, A DELAWARE LIMITED LIABILITY COMPANY, AS GRANTOR; SYSTAGENIX WOUND MANAGEMENT (US), INC., A DELAWARE CORPORATION, AS GRANTOR
Reel/Frame 041395/0044 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
RELEASE OF SECURITY INTEREST Recorded Sep 21, 2016
From: WILMINGTON TRUST
To: KCI LICENSING, INC.; LIFECELL CORPORATION; KINETIC CONCEPTS, INC.; TECHNIMOTION, LLC
Reel/Frame 040098/0200 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
SECURITY AGREEMENT Recorded Nov 8, 2011
From: KCI LICENSING, INC.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 027194/0447 →
SECURITY AGREEMENT Recorded Nov 7, 2011
From: KCI LICENSING, INC.; LIFECELL CORPORATION; TECHNIMOTION, LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 027185/0174 →
PATENT RELEASE Recorded Nov 4, 2011
From: MORGAN STANLEY & CO. LLC F/K/A MORGAN STANLEY & CO. INC., AS ADMINSTRATIVE AGENT
To: KCI LICENSING, INC.
Reel/Frame 027181/0420 →
TERMINATION OF SECURITY INTEREST IN PATENTS Recorded Jan 7, 2011
From: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
To: KINETIC CONCEPTS, INC.; KCI LICENSING, INC.; LIFECELL CORPORATION
Reel/Frame 025599/0904 →